Products with Converted Labeling Reference Studies for the Pregnancy and Lactation Rule for the Development of the Pregnancy Safety Study Framework & Use in Pregnancy Read more about Products with Converted Labeling Reference Studies for the Pregnancy and Lactation Rule for the Development of the Pregnancy Safety Study Framework
Outcome Monitoring Following Faricimab Use: A Self-Controlled Risk Interval Signal Identification Analysis Read more about Outcome Monitoring Following Faricimab Use: A Self-Controlled Risk Interval Signal Identification Analysis
Duration of Follow Up for New Molecular Entities Approved in 2019: Third Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2019: Third Descriptive Analysis
Duration of Follow Up for New Molecular Entities Approved in 2018: Third Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2018: Third Descriptive Analysis
Utilization of Amyloid Beta-Directed Monoclonal Antibodies: A Descriptive Analysis Read more about Utilization of Amyloid Beta-Directed Monoclonal Antibodies: A Descriptive Analysis
Duration of Follow Up for New Molecular Entities Approved 2020: Second Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved 2020: Second Descriptive Analysis
Assessment of ARIA Sufficiency: Lymphir (denileukin diftitox-cxdl) Read more about Lymphir (denileukin diftitox-cxdl)